Mirtazapina Teva (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Teva, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It works by modulating central neurotransmitters and is indicated for the management of major depressive disorder in adult patients, helping to improve mood, sleep and appetite.

GNH USA supplies Mirtazapina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global healthcare providers and ensuring product quality throughout the supply chain.

Mirtazapine is used to treat depressive disorders by influencing serotonergic and noradrenergic pathways.

Major depressive disorder (acute): reduces core depressive symptoms and improves overall mood. Major depressive disorder (maintenance): helps prevent relapse after initial response. Depressive symptoms with insomnia: promotes sleep and appetite normalization.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation - Dizziness - Fatigue

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Severe hypotension or syncope - Seizures - Suicidal ideation or behavior - Hepatic dysfunction - Blood dyscrasias such as thrombocytopenia

Mirtazapine should be used with caution in several clinical situations. - Assess cardiovascular status: monitor for orthostatic hypotension, especially in the elderly. - Evaluate hepatic function: dose adjustment may be required in patients with liver impairment. - Screen for suicidal thoughts: heightened risk during early treatment phases. - Avoid abrupt discontinuation: taper gradually under medical supervision to prevent withdrawal symptoms. - Caution in elderly: increased sensitivity to sedation and anticholinergic effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mirtazapine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - CNS depressants (e.g., benzodiazepines, opioids): enhanced sedation and respiratory depression. - Strong CYP2D6 inhibitors: increased mirtazapine plasma concentrations.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Anticholinergic agents: additive anticholinergic burden. - Alcohol: increased central nervous system depression and impaired coordination.